162 related articles for article (PubMed ID: 23023608)
1. [Secondary prevention of venous thromboembolism].
Bauersachs RM
Dtsch Med Wochenschr; 2012 Oct; 137(40):1994-7. PubMed ID: 23023608
[No Abstract] [Full Text] [Related]
2. Venous thromboembolism: risk factors for recurrence.
Zhu T; Martinez I; Emmerich J
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
[TBL] [Abstract][Full Text] [Related]
3. [Prevention and treatment of venous thromboembolism in patients with cancer].
Struve S; Wendtner CM
Dtsch Med Wochenschr; 2012 Oct; 137(40):2007-9. PubMed ID: 22987155
[No Abstract] [Full Text] [Related]
4. The 8(th) American College of Chest Physicians Guidelines - a perspective on venous thromboembolism guidelines.
Squizzato A; Ageno W
Thromb Haemost; 2009 Jan; 101(1):31-5. PubMed ID: 19132186
[No Abstract] [Full Text] [Related]
5. [The optimal duration of anticoagulant treatment following pulmonary embolism].
Couturaud F
Rev Mal Respir; 2011 Dec; 28(10):1265-77. PubMed ID: 22152935
[TBL] [Abstract][Full Text] [Related]
6. [Risk factors for recurrent venous thromboembolism].
Rosencher J; Mirault T; Martinez I; Zhu T; Messas E; Emmerich J
Rev Mal Respir; 2011 Apr; 28(4):453-62. PubMed ID: 21549901
[TBL] [Abstract][Full Text] [Related]
7. Compliance with recommendations of clinical practice in the management of venous thromboembolism in cancer: the CARMEN study.
Sevestre MA; Belizna C; Durant C; Bosson JL; Vedrine L; Cajfinger F; Debourdeau P; Farge D;
J Mal Vasc; 2014 May; 39(3):161-8. PubMed ID: 24746736
[TBL] [Abstract][Full Text] [Related]
8. Preventing recurrent venous thromboembolism.
Drug Ther Bull; 2009 Apr; 47(4):38-40. PubMed ID: 19357297
[TBL] [Abstract][Full Text] [Related]
9. The problem of risk assessment and prophylaxis of venous thromboembolism in pregnancy.
Krafft A
Thromb Haemost; 2007 Dec; 98(6):1155-6. PubMed ID: 18064306
[No Abstract] [Full Text] [Related]
10. Anticoagulants for thrombosis prophylaxis following surgery: a continuing saga.
Caprini JA
Thromb Haemost; 2008 Jun; 99(6):993-4. PubMed ID: 18521498
[No Abstract] [Full Text] [Related]
11. Duration of anticoagulant treatment and recurrence of venous thromboembolism in patients with and without thrombophilic abnormalities.
Taliani MR; Becattini C; Agnelli G; Prandoni P; Moia M; Bazzan M; Salvi R; Ageno W; Guazzaloca G; Imberti D; Silingardi M; Poggio R;
Thromb Haemost; 2009 Mar; 101(3):596-8. PubMed ID: 19277429
[No Abstract] [Full Text] [Related]
12. What is the optimal duration of treatment for DVT? An update on evidence-based medicine of treatment for DVT.
East AT; Wakefield TW
Semin Vasc Surg; 2010 Sep; 23(3):182-91. PubMed ID: 20826296
[TBL] [Abstract][Full Text] [Related]
13. Prevention of venous thromboembolism in the cancer surgical patient.
Kakkar AK
J Clin Oncol; 2009 Oct; 27(29):4881-4. PubMed ID: 19738112
[TBL] [Abstract][Full Text] [Related]
14. Low-molecular-weight heparin versus placebo for the prevention of venous thromboembolism in metastatic breast cancer or stage III/IV lung cancer.
Haas SK; Freund M; Heigener D; Heilmann L; Kemkes-Matthes B; von Tempelhoff GF; Melzer N; Kakkar AK;
Clin Appl Thromb Hemost; 2012; 18(2):159-65. PubMed ID: 22275397
[TBL] [Abstract][Full Text] [Related]
15. [Introduction. Venous thromboembolism in cancer patients].
Martínez del Prado P
Med Clin (Barc); 2015 Jan; 144 Suppl 1():1-2. PubMed ID: 25771085
[No Abstract] [Full Text] [Related]
16. Improve the results of phase II trials of thromboprophylaxis with the new oral anticoagulant drugs.
Zufferey PJ; Samama CM; Rosencher N
Thromb Haemost; 2010 Dec; 104(6):1083-4. PubMed ID: 20886198
[No Abstract] [Full Text] [Related]
17. [Thromboembolic disease: the challenge is in the prophylaxis].
Rabuñal Rey R
Rev Clin Esp; 2012 Apr; 212(4):184-5. PubMed ID: 22402375
[No Abstract] [Full Text] [Related]
18. [Prophylaxis of venous thromboembolism in patients with cancer].
Schinzel H
MMW Fortschr Med; 2012 Aug; 154(14):50-2. PubMed ID: 22957456
[No Abstract] [Full Text] [Related]
19. Prevention of venous thromboembolism in total knee and hip replacement.
Warwick D
Circulation; 2012 May; 125(17):2151-5. PubMed ID: 22547755
[No Abstract] [Full Text] [Related]
20. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
Ridker PM; Goldhaber SZ; Danielson E; Rosenberg Y; Eby CS; Deitcher SR; Cushman M; Moll S; Kessler CM; Elliott CG; Paulson R; Wong T; Bauer KA; Schwartz BA; Miletich JP; Bounameaux H; Glynn RJ;
N Engl J Med; 2003 Apr; 348(15):1425-34. PubMed ID: 12601075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
